Hi CFUsersIf CFU don`t come up with similar issues, the market may become very attractive , not that it isn`t already, for CFU.I expect that since CFU have been testing a lot longer than Ceres at more sites with greater numbers it won`t become an issue.So good luck to us and bad luck for Cereshttp://uk.reuters.com/article/2011/03/30/markets-europe-stocksnews-idUKLDE72T0QX20110330I`m giving a buy because of the clapped out SPG
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
